Am J Transplant, Volume 17, Suppl 3 Archives - Page 181 of 181 - ATC Abstracts

2017 American Transplant Congress
Prognostic Tools to Choose Candidates for Successful Desensitization.
D. Pinelli,¹ A. Zachary,² J. Friedewald,¹ M. Leffell,² D. Lucas,² R. Montgomery,² A. Tambur.¹
¹Northwestern University, Chicago, IL; ²Johns Hopkins, Baltimore, MD
Antibodies to donor HLA antigens are a barrier to solid organ transplantation. Strategies to desensitize patients have improved, but the ability to predict response to…
2017 American Transplant Congress
Hepatic Artery and Biliary Complications in Liver Transplant Recipients with Radioembolization Bridging Treatment for Hepatocellular Carcinoma.
S. Radunz,¹ J. Treckmann,¹ F. Saner,¹ S. Müller,² J. Theysohn,³ A. Paul,¹ T. Benkö.¹
¹General, Visceral and Transplant Surgery, University Hospital Essen, Essen, Germany; ²Nuclear Medicine, University Hospital Essen, Essen, Germany; ³Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
Locoregional treatments are commonly applied in hepatocellular carcinoma (HCC) patients as a bridge to liver transplantation to prevent tumor progression during waiting time. We hypothesized…
2017 American Transplant Congress
Outcomes Following Transplantation for Hepatocellular Carcinoma.
P. Tabrizian, K. Nakazawa, J. Prigoff, M. Schwartz, S. Florman.
Transplant, Recanati/Miller Transplantation Institute, New York, Ny
Objectives: To examine the prognostic features and outcomes of patients undergoing transplantation for hepatocellular carcinoma (HCC).Methods: A single-institution retrospective chart review was performed on all…
2017 American Transplant Congress
The Impact of the Kidney Allocation System on Outcomes for Kidneys with KDPI > 85%.
A. Perry,¹ J. Sageshima,¹ C. Santhanakrishnan,¹ J. McVicar,¹ C. Troppmann,¹ A. De Mattos,² J. Woloszyn,¹ R. Perez.¹
¹Division of Transplant Surgery, University of California, Davis, Sacramento, CA; ²Division of Transplant Medicine, University of California, Davis, Sacramento, CA
Single center outcomes were examined to assess the impact of the implementation of the Kidney Allocation System (KAS) on outcomes for kidneys with KDPI >85%.Methods:…
2017 American Transplant Congress
Zero-Time Biopsy of Potential Donor Kidneys to Aid Decision-Making: A 9-Year Single-Center Experience.
Y. Luque, O. Aubert, F. Martinez, L. Amrouche, C. Tinel, L. Galmiche, L.-H. Noel, J.-P. Duong, F. Audenet, C. Legendre, D. Anglicheau, M. Rabant.
Necker-Enfants Malades, Tenon and European Georges Pompidou Hospitals, Paris, France
The added benefits of zero-time biopsy of a potential donor kidney on top of standard donor biological and clinical data to aid in the decision…
2017 American Transplant Congress
The Role of Urinary Chemokines in Distinguishing Causes of Renal Allograft Dysfunction.
S. Chong,¹ R. Fernando,² M. Harber,¹ C. Magee.¹
¹UCL Centre for Nephrology, Royal Free Hospital, London, United Kingdom; ²Anthony Nolan Laboratories, Royal Free Hospital, London, United Kingdom
The aetiology of renal transplant dysfunction is varied, and diagnosis often relies upon transplant biopsy, an invasive procedure that carries significant risk. Availability of a…